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Summary We report a fatal case of disseminated Mycobacterium simiae infection in an immu-
nocompetentelderlymanwith feverofunknownorigin. Thediagnosiswasbasedonculture isolation
ofnon-tuberculousmycobacteria fromcerebrospinalfluid andbronchoalveolar lavage.Both culture
isolates were identified as M. simiae by 16S rRNA gene sequencing.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Mycobacterium simiae is a slow-growing non-tuberculous
mycobacterium (NTM). It is transmitted by inhalation of aero-
sols or by inoculation.1 Its disease spectrum ranges from
localized pulmonary infection in immunocompetent patients
with underlying pulmonary disease to a disseminated disease
in immunocompromised patients, especially those infected
with HIV.2—5 The absence of reports on the simultaneous
recovery of M. simiae from the central nervous system
and bronchoalveolar lavage in immunocompetent patients
prompted this communication.We reportM. simiae as a cause
of disseminated infection in a non-HIV patient and identifyM.
simiae as a cause of fever of unknown origin (FUO).
Case report
An 83-year-old male ex-smoker with no known previous
pulmonary disease presented to the American University of* Corresponding author. Tel.: +961 1 350000.
E-mail address: sk11@aub.edu.lb (S.S. Kanj).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.10.015Beirut Medical Center for a right hip fracture after a fall and
underwent hemiarthroplasty. The patient complained of
feeling ill for several weeks before admission. Two days
post-operatively, he developed fever accompanied by con-
fusion and agitation. Physical exam revealed bibasilar
crackles on chest auscultation, but was otherwise unremark-
able. Chest radiograph showed bilateral interstitial infil-
trates. The white blood cell count was 28 000 cells/mm3,
with 93% neutrophils. A diagnosis of hospital-acquired pneu-
monia was suspected and the patient was empirically treated
with cefepime. The fever persisted, with deterioration of the
patient’s level of consciousness. He also developed abdom-
inal distension and respiratory distress that necessitated
intubation and mechanical ventilation. Blood, sputum and
urine cultures revealed no microorganisms. A CT scan of the
brain showed small-vessel ischemic disease. A CT scan of the
abdomen and pelvis showed diffuse colonic distension con-
sistent with ileus, and bilateral consolidation of the lower
lung lobes. Dialysis was started after the patient became
anuric, with elevation of the serum creatinine to 2.7 mg/dl.
The patient continued to have fever with a persistently
elevated white blood cell count. Bronchoscopy was done
on day 11 of hospitalization and bronchoalveolar lavagePublished by Elsevier Ltd. All rights reserved.
Fatal disseminated Mycobacterium simiae infection in a non-HIV patient 287(BAL) was sent for bacterial, fungal and mycobacterial cul-
tures. The BAL culture grew extended-spectrum b-lacta-
mase-producing Klebsiella pneumoniae and Acinetobacter
baumannii, for which he received imipenem without
improvement. Lumbar puncture was done on day 13 and
showed one white blood cell, with normal glucose and pro-
tein levels in the cerebrospinal fluid (CSF). CSF was sent for
bacterial, fungal and mycobacterial cultures. Hepatitis B and
C, HIVand Brucella serology were all negative. Because of the
leukemoid reaction, a bone marrow biopsy was done to rule
out tuberculosis and revealed myeloid hyperplasia with no
granulomas. The purified protein derivative (PPD) test was
performed twice during his hospital stay and was negative.
On days 18 and 20 of hospitalization, cultures of BAL and CSF,
respectively, grew an NTM. The patient developed cardio-
pulmonary arrest and could not be resuscitated.16S rRNA
gene sequencing of the first 500 base pairs of both the CSF
and BAL isolates identified the NTM as M. simiae.
Discussion
M. simiae has been recognized as an agent of human pul-
monary disease in patients with AIDS, as well as in immuno-
competent patients with a variety of underlying lung diseases
and in immunosuppressed patients.2—4,6—7 M. simiae is a
slow-growing NTM, but can be recovered within seven days
using the BACTEC-TB system (Becton Dickinson Microbiology
Systems, Cockeysville, MD, USA).
M. simiae seems to be an emerging pathogen in the Middle
East. In a review of NTM isolates from respiratory specimens
at a tertiary care center in Israel, M. simiae was found to be
the most common.8 A recent multicenter study, also from
Israel, revealedM. simiae to be themost common pathogenic
Mycobacterium species in cystic fibrosis patients.9 Over the
past three years, 16S rRNA gene sequencing performed on
isolates recovered in the Clinical Microbiology section of the
Department of Pathology and Laboratory Medicine (American
University of Beirut Medical Center) revealedM. simiae to be
the most common NTM in respiratory specimens (Kattar M.M.
and Araj G.F., unpublished). A series of ten AIDS patients with
disseminated M. simiae infection has been reported.5 All
patients in this series, except for one, had a CD4 T-lympho-
cyte cell count of <50 cells/ml.
Our patient is the first case of disseminated M. simiae
infection in a non-HIV immunocompetent patient. It is very
likely that the infection was incubating before admission to
the hospital and manifested after the stress of the fall and
operation. It is worth noting that this is the first reported case
of M. simiae isolated from the CSF and the second case of M.
simiae isolated from central nervous tissue. Valero et al.
reported the first case of M. simiae isolated from brain tissue
in an AIDS patient with central nervous system lymphoma.10
Despite the fact that there was no biochemical evidence
of meningitis, the positive culture from the CSF suggests
early seeding of the meninges. The patient’s clinical picture
was suggestive of a mycobacterial infection presenting as
FUO with a leukemoid reaction. There is a tendency to
ignore isolates of NTM as contaminants when they do not
meet the ATS/IDSA criteria of NTM pulmonary disease.11,12Although diagnosing NTM infection requires the presence of
pulmonary symptoms, compatible radiographic findings and
exclusion of other diagnoses, with bacteriologic evidence of
NTM according to the ATS/IDSA criteria, it is also true that
these criteria have been most studied in infections due to
Mycobacterium avium complex, Mycobacterium kansasii
and Mycobacterium abscessus. Careful evaluation and sus-
picion of NTM infections is recommended in view of their
increasingly recognized role as causative agents of both
pulmonary and non-pulmonary infections. Despite the lack
of a positive blood culture for mycobacteria, the recovery
of M. simiae from two sites, including bronchoalveolar
lavage and a sterile body site, strongly supports the dis-
seminated nature of this infection. Of note is that samples
from the lung and CSF were collected and processed on
different dates with negative controls. In addition, during
the period of isolation, there were no other positive cul-
tures for M. simiae from other patient samples to suggest
possible laboratory contamination. NTM including M simiae
should be considered a possible causative agent of pulmon-
ary disease or FUO. When isolated from normally sterile
sources, they should be considered clinically relevant,
whereas isolation from other sources necessitates close
clinical evaluation with repeat cultures.
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